Yogesh Waman

Title: Innovations of Yogesh Waman in Pharmaceutical Development

Introduction

Yogesh Waman is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors associated with various diseases. His work is characterized by a focus on innovative solutions for complex medical conditions.

Latest Patents

Yogesh Waman holds a patent for a compound titled "1-Substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as EP4 receptor antagonists." This invention provides a compound represented by a specific formula, which exhibits EP4 receptor antagonistic action. It is useful as an agent for the prophylaxis or treatment of EP4 receptor-associated diseases, including rheumatoid arthritis, aortic aneurysms, endometriosis, ankylosing spondylitis, and inflammatory breast cancer. He has 1 patent to his name.

Career Highlights

Yogesh Waman is currently associated with Takeda Pharmaceutical Company Limited, where he continues to engage in groundbreaking research and development. His work at Takeda emphasizes the importance of innovative therapeutic solutions in addressing unmet medical needs.

Collaborations

Yogesh collaborates with talented professionals in his field, including coworkers Santosh Patil and Anil Panmand. Their collective expertise contributes to the advancement of pharmaceutical innovations.

Conclusion

Yogesh Waman's contributions to pharmaceutical development highlight the importance of innovation in addressing complex health issues. His patent for EP4 receptor antagonists exemplifies the potential for new treatments in the medical field.